 [8] 
  Given this last event, the Applicants seek an order under Rule 75 of the Federal Court Rules to amend their Notice of Application as follows: 
 
 
 
 i) add the following prayer for relief after paragraph D: 
 
 
 
 E. An Order requiring the Minister of Health to revoke the Notice of Compliance issued to Apotex Inc. on or about February 1, 2007 for Apo-Perindopril 8 mg tablets. 
 
 
 
 ii) add the following after paragraph 11: 
 
 
 
 12. On or about February 1, 2007 the Minister of Health issued a Notice of Compliance to Apotex Inc. for Apo-Perindopril 8 mg tablets. 
 
 
 
 Moreover, the Applicants seek the following orders from the Court: 
 
 
 
 i) An order confirming that the affidavit of Denise Pope dated February 13, 2007 filed in support of the present motion is deemed to form part of the record before this Court for the purpose of hearing the application on the merits. 
 
 
 
 ii) An order setting this matter down for hearing on the merits for one half day on the earliest available date after March 20, 2007. 
 
 
 
 iii) An order setting the following schedule for pre-hearing steps: 
 
 
 
 a. Ms. Bowes’ cross-examination to be completed by February 21, 2007. 
 
 
 
 b. Applicants’ record to be served and filed by February 28, 2007. 
 
 
 
 c. Respondents’ records to be served and filed within 20 days of the date that the Applicants’ record is filed. 
 
 
 
 II.  
 Issues 
 
 
 
 (1) Is the Minister of Health’s issuance of a NOC to Apotex, for Apo-perindopril 8 mg tablets, a separate and distinct decision from the Minister’s December 12, 2005 finding that the PMNOC Regulations do not apply to Apo-perindopril 8 mg tablets? 
 
 
 
 III.  
 Analysis 
 
 
 
 (1) Is the Minister of Health’s issuance of a NOC to Apotex, for Apo-perindopril 8 mg tablets, a separate and distinct decision from the Minister’s December 12, 2005 finding that the PMNOC Regulations do not apply to Apo-perindopril 8 mg tablets?